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Review of ten years' home dialysis. J. F. Moorhead. Royal
Free Hospital, London, Englan'L Home hemodialysis was started
at the Royal Free Hospital in 1964. Ten of the first 14
patients are still alive eight to ten years later and 50 patients
have completed over five years home dialysis. Selection of
patients, methods of management and training and equipment
have varied over the years in keeping with new developments,
and transplantation was introduced in 1968. This paper reviews
the quality of dialysis achieved in relation to a) morbidity
and mortality, b) patient selection, c) training techniques,
d) patient ability and intelligence, e) home and social back-
ground and /) patient achievements. Only 7 of the 153 patients
established on home dialysis have been returned to hospital
dialysis. Forty-three patients received cadaveric renal trans-
plants of which 20 are still functidning; 16 patients returned
to home dialysis and 7 died. In those patients on home dialysis
there were 14 deaths of which 4 occurred while on dialysis at
home. Apart from renal failure secondary to systemic disease,
mortality seems to have no relationship to patient selection
or ability to dialyze. However, medical and social morbidity
has a direct relationship to the personality of the patient and
his interwoven relationships within the family.
Dialytic strategies and the removal of methylguanidine (MG)
from body fluids. S. Giovannetti, P. Rindi, and G. Barsotti
Semeiotica Medica, Universial, Fisa, Italy. It has been recently
found that the binding to plasma proteins and the preferential
distribution of MG in the intracellular fluid compartment strong-
ly affect its dialytic removal. The tong duration peritoneal
dialyses allow adequate removal of MG because an equilibrium
may exist through their duration between the intra- and the
extracellular MG. It follows that, even in the late hours, relative-
ly high amounts of MG are available in plasma for the dialytic
removal. Similar conditions are obtained in the "low dialysate
flow rate hemodialyses." Contrarily, the highly efficient hemo-
dialyses induce a rapid fall of the extracellular MG while its
intracellular concentration remains relatively high. It follows
that low amounts of MG are available for dialysis in the late
hours and very high postdialysis rebounds of the MG plasma
concentrations occur. Highly efficient and short hemodialyses
performed frequently seem to be the most advantageous hemo-
dialysis strategyas far as the removal of MG is concerned.
A full account of the Meeting will appear in the Proceedings
of the EDTA by March 1975.
Ab Gambro (Sweden) has kindly assisted with the publica-
iton of the abstracta
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Short dialysis schedules (SDS): Finally ready to become a
routine? V. Cambi, L. Ansi, L Bignardi, G. Bruschi, E. Ross4
G. Savazzi and L. Migone. II din. Med., Parma, Italy. In the
last three years more than 90 consecutive patients (P), the total
unselected population of a single renal unit, were treated with
SDS for > 20.000 runs 50 were treated for at least two years;
single treatment duration: 3 to 4 hr (10-12 hr weekly); dialyzers:
1 m2. The continued lack of neuropathy was confmned by
further EMG studies. A stable Hct of 27.2 5.7%, maintained
without blood transfusions, is significantly better than that of
traditionally treated patients (Hct, 22.3 4.2%). Large individual
differences in predialysis retention of small molecules and/or
residual urine output and body suggest that the flexibility of
weekly duration and frequency is still very large. Consequently,.
the chances for a further reduction of dialysis time and frequency
were considered. Presently 15 P (4 anuric) have been treated
from 6 to 9 hr weekly up to 13 months (all are continuing the
trial). A single run never exceeds 3 hr. Larger surface areas
(1.5 m2) are rarely needed to prevent high levels of K and P.
Conservative patients with severe anemia (Hct < 20%) or
neuropathy (peroneal 25 m/sec) in spite of a "good" creatinine
clearance (S ml/min), treated with no more than 3 hr twice
weekly, showed 50% improvement of anemia and MNCV. The
rapid improvement shown by this type of "early" dialysis an-
ticipates and strengthens social rehabilitation. Conclusion: SDS
are presently advisable to every patient.
Clinical evaluations of patients dialyzed with 2 gambro four
hours three times per week. K. S. Mfrahmadz I. H. Kaye, I. H.
Millerand .1. T. Gorman. VA Hospitals, Long Beach, Sepulveda
and Wadsworth, Long Beach and Los Angeles, California, and
Depts. of MeL, UCI and UCLA Schools of Med., Irvine and
Los Angeles, California, U. S. A. To reduce hours and cost of
each dialysis and/or to increase adequacy of hemodialysis treat-
ment, 14 chronic dialysis patients were dialyzed with 2 Gambro,
four hours/day, three days/week for 3 to 13 months' study
period (SP). All patients had been on coil dialyzers six hours!
day, two to three days/week for 3 to 13 months' control period
(CP) prior to SP. Gambro dialyzers were reused 6 to 18 times
with an average of times. Clearance data were obtained with
multiple reuse. All clinical data from SP were compared with CP.
General well-being improved in SP. Anemia improved in ten
patients but did not change in four patients during SP. Nerve
conduction velocity improved in two patients, no change was
noted in nine patients and in one patient progressive neuropathy
which developed during CP was arrested in SP. Clearance of 2
Gambro dialyzers was not reduced significantly during reuse. In-
creasing dialysis surface area by using 2 Gambro enabled reduc-
tion of hours of dialysis which was favorably accepted by all
2A Abstracts
patients. This increased working capacity of patients and de-
creased cost of dialysis mainly by increasing capacity of a unit
to dialyze more patients with the same nursing personnel. Low
leak rate and feasibility for more reuse in Gainbro dialyzers de-
creased cost of each dialysis. Better clearance of small and
middle molecule uremic toxins could have caused improvement
in general well-being, anemia and uremic neuropathy in some
patients. This is one more step toward short, cheap dialysis with
semidisposable dialyzers.
One year's experience with brief "daily" dialysis. D. Snyder,
B. Louis and P. Gorfien. Maimonides Medical Center, Brooklyn,
New York, U. S. A. Six patients were treated with "daily" (five
days per week) dialysis for a total of 80 patient months. Dialysis
was performed for two hours per day using a one M2 coil in a
RSP system. The Vital Assist single needle device and multiple
coil reuse utilizing the Medigenic Inc. system was used in all
dialyses. All six patients were transferred from our standard out-
patient dialysis program (three five-hour dialyses/week). Serial
nerve conduction studies, bone biopsies and psychological testing
were performed and standard renal chemistries were evaluated.
Predialysis chemistries fall in a smooth slope from Monday
through Friday. The mean predialysis values on Monday and
Friday for BUN and creatinine are, respectively: BUN, 102.13
to 80.04; creatinine, 15.60 to 11.95 mg/100 ml. During the
period of observation there was no evidence of deterioration in.
nerve conduction studies or osteodystrophy. Patient acceptance
was excellent with a substantial improvement in their sense of
well-being and a complete loss of fear and anger toward dialysis.
The new schedule permitted a return to a normal work week and
home-life. A 38% reduction in the total cost per dialysis was
achieved. There was an 84% reduction in coil ruptures, a 52%
reduction in fistula problems and a total absence of postdialysis
fatigue and depression. Intradialysis hemodynamic complications
and cramps disappeared. There is no current evidence of an ac-
cumulation in the serum of substances which are detrimental to
the patient's medical well-being. These advantages suggest that
daily dialysis at home or in a center is preferable to the inter-
mittent schedule.
Use of a mathematical single-pool model for calculating and
control of short-time hemodialysis. T Widerfie, L. Grimsrud,
K. J. Berg, R. Jensen and S. JØrstad. Central Hospital, Trond-
heim, and Norwegian Institute of Technology, Trondheim,
Norway. A mathematical one-pool analog simulation of a patient
dialyzer system has been used in determining the individual
dialysis requirement. By varying the membrane area and blood
flow, the treatment time has been halted. Compared with a
standard program, the calculated removal of urea and creatinine
has been equal and that of the middle molecules equal or better.
The model has been formed in a nomogram for practical and
clinical use. Seven patients have been compared during a stan-
dard program (mean observation time, 10.1 months) and later
during an individual calculated short time program (mean ob-
servation time, 6.3 months). Mean results of 750 standard treat-
ments and 550 short-time treatments are shown in the table.
Mean value
during
dialysis,
mg/100 ml.
Program Q0 Q Membranearea, m2 Hours!week Crea-Urea tinine
Standard
Short-time
175
275
500
500
0.85
1.25
27
13.5
110 10.5
112 10.2
BP, Hct and transferrin were unchanged and motor NCV normal
(46.4 to 70.8). Hypotension was three times as frequent during
short-time dialysis compared with standard treatment (11% vs.
4%) and cramps in the lower limbs two times as frequent (4%
vs. 2%). Symptoms of osmotic disequilibrium did not show any
difference (4%). All seven patients preferred short-time dialysis.
The mathematical method was exactly and practical enough for
clinical routine. The limiting factor is not waste products re-
moval, but the complication of vigorous ultrafiltration.
Short-time personalyzed dialysis: Good results in spite of
high levels of small and middle molecules. R. Majorca, A. Castel-
lani, G. Migozzi, G. 0. Panzetta and M Usberti. Division of
Nephrology, Spedali Civili Brescia, Italy. Sixteen anuric patients
and eight with residual GFR were treated with pràgressively
shortened schedules: Kiil st ten hours three times a week; Gam-
bro L, four or five hours three times a week; and now all with
Gambro Nova or Dow Cordis 4, four hours three times a week.
Each treatment lasted at least six months. Q8250, Q500. Per-
sonalyzed dialysis fluid content on acetate and K was used to
maintain normal predialytic levels of H and K. Arterial pres-
sure was normal in all but two without hypot. drugs or
binephrectomy. Hct was 32 8% with Fe 2 to 3 g/yr i.v. and
protein intake> 1.2 g/kg/day. Ca X P was 46 13 with AIOH2
1 to 2 g/day. Sixty clinical indicators checked at each dialysis
were analyzed with three IBM 24 K systems. In spite of signifi-
cant increase of little and middle molecules, all patients are in
excellent clinical condition, subjectively better than with the
standard Kill schedule, ten hours three times a week. 92% of
patients are able to work. No significant differences were ob-
served on Ivy time, Hct, median and peroneal nerve conduction
velocity, i.v. glucose tolerance test (Conard K), serum phos-
phorus, etc. in patients on shortened dialysis schedules. No
significant differences in anuric vs. patients with residual GFR
were noted. Conclusions: Good control of fluids, pH, electro-
lytes and of anemia is presumably the most important factor in
dialysis.
Short-time dialysis with 2M2 hollow fiber kidney. T. Man/i,
K Maeda, S. Kawaguchi, K. Kobayashi, K Ohta, A. Saito,
I. Aniano and T. Shimo/i. Nagoya University Branch Hospital
and Chukyo Hospital, Nagoya, Japan. Three-hour dialysis is con-
ducted successfully with 2M2 surface area HFK of cupram-
monium rayon at a blood flow of 300 ml/min, In theoretical
study, it is necessary for a short-time dialysis to increase not
only membrane area but also blood flow. Clinical observation
of one renal failure patient treated with 2M2 HFK was made
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—AKfor one year. From the formula, D = QB (1-exp ----, inorder
to get twice the dialysance over 1M2 membrane area at QB =
200 mI/mm, 2M2 membrane area and a blood flow of 400
mi/mm are required. In this case, removal of low molecules
such as urea are greatly influenced by the increased QB, and
middle molecules as inulin, by the increased membrane area.
In practice, it is difficult to gain the blood flow of more than
400 mi/mm for all the patients; therefore, doubled dialysance is
obtained with 2M2 kidney at QB = 300 mI/mm by decreasing
resistance across the membrane in the dialysate compartment.
Using 2M2 HFK keeping blood flow at 300 mI/mm, three-hour
dialysis is conducted in patients for one year and, clinically, any
adverse effects axe not seen. For the practice of short-time
dialysis, theoretically, increased membrane area and blood flow
are required and, clinically, there must not be any disequiib-
riuin syndromes. We are able to conduct three-hour dialysis
without any symptoms in patients using 2M2 HFK at QB 300
mi/mm and 30-liter dialysate system with adsorbents.
Ultrafiltration: An effective method for the removal of
'middle molecular' substances from the blood of uremic patients.
I. Rieger, E. Quellhorst, H. D. Lowitz and R. G. Kong. Nephro-
logisches Zentrum Niedersach sea, Hann Muenden, W. Germany.
In order to compare the effectiveness of blood ultrafiltration
with dialysis concerning "middle molecules", a plate ultrafilter
with cellulose nitrate membranes and a Kill dialyzer were used
to measure the clearances of the following substances: urea (mol
wt, 60), creatinine (113), 14C-EDTA (294), 3H-ouabain (594),
3H-Vit. B12 (1355) and 14C-inulin (5000). Dialysis was more
effective than ultrafiltration in removing substances of mol wts
up to 300. Larger molecules could be eliminated by ultrafiltra-
tion only. There was a strong correlation between filtrate
volume and clearances of 3H-ouabain and Vit. 1
. Inulinwas
retained to a larger extent. With increasing filtrate volume, the
relation of clearances of larger molecules to clearances of sub-
stances with a smaller inol wt could be changed in favor of
larger molecules. An extensive loss of amino acids was found
during ultrafiltration. In spite of this fact, ultrafiltration is the
only method of removing substances with a larger mol wt than
300 within a short time.
An Up-to-date appraisal of single needle dialysis. K. F. Kopp,
U. Schmidt, H. Fistor, S. Hughes, D. Van Dura, G.. Ramirez and
1+'. 1. Koiff U of Utah Home Dialysis Training Ctr., Techn. U.
Munich, II Med., Fed. DiaL Ctr., Munich-Schwabing. Single
Needle Dialysis (SND) according to the method published by
Kopp, Gutch and Kolff in 1972 permits hemodialysis through a
single entry into a blood vessel. Since mid-1971 through March
1974, a total of 66 patients were trained by us in the use of
SND for home dialysis at three different institutions. In addi-
tion, many incenter patients have been regularly treated by SND.
The patients fall into two groups: those started on SND (40),
and those converted to it from either shunt or double needle
dialysis (DND) (26). The latter were converted most commonly
because of problems in blood access. In cases of well-dialyzed
DND or shunt patients, conversion to SND was accomplished
with blood chemistries and hematologic fmdings staying within
the same range. The patients' clinical conditions frequently im-
proved. Proper understanding of the flow pattern and of all
operational indexes of SND is essential. For this purpose pro-
cedures have been established which have been successfully ap-
plied to all types of dialyzers and dialysia machines in use in
Europe and the U.S.A. Further improvement of catheters and
blood tubing designs have been developed and tested. Significant
technical advancement has also been accomplished with SND
monitoring devices. In our experience the main objectives of
SND, reduction of pain and vascular trauma and prolongation of
life of the A-V fistula, have been met. The ease of application
and lack of complications has led us to apply SND as a routine
procedure to all fistula patients.
A new way to regenerate the dialysis fluid. E. Petrelta, G.
Orlandini and L. Bigi. Dialysis Unit, Ospedale Fiacenza and
Belico Laboratories, Mirandola, Italy. Many previous experiences
have proven the ability of activated carbon in retaining great
quantities of uremic toxins. Urea and phosphate removal repre-
sents the major obstacle for which the systems until now pro-
posed resolve inadequately or with undesirable side-effects (re-
moval of Ca, Mg) likely associated to toxic reactions. In our
system 10 liters of dialysate are recirculated from a reservoir
through a cartridge containing activated carbon, superactivated
oxystarch (which guarantees urea withdrawal) and other inorganic
substances basically composed of aluminum and silicon oxide
(which retains phosphates). Dialysate is then passed through the
dialyzer and returned to the reservoir. The in vitro and in vivo
experiments (on dogs) have given optimum results on uremic
toxins removal. A modified formula of dialysis fluid has allowed
correction of the electrolyte abnormalities and achievement of
the acid-base equilibrium of the blood. No signs of toxicity were
revealed. This new system, simple and economical, should be
useful for the treatment of acute and chronic uremia.
Ten-liter dialysate supply system with adsorbents. K Maeda,
T. Man/i, S. Kawaguchi, K. Kobayashi, K Ohta and A. Salto,
Nagoya University Branch Hospital and Chukyo Hospital,
Nagoya, Japan. Twenty-seven chronic renal failure patients have
been treated with a portable machine of 30-liter dialysate with
adsorbents for two years. They have no uremic neuropathy,
ectopic calcification nor itching. Urea reduction rate with this
machine is worse than in conventional hemodialysis, but reduc-
tion rates of creatinine and uric acid are higher than with a
single-pass system. All of them have maintained well-being. In
these two years of clinical experience, dialysate volume has been
lowered to 10 liters. Five hundreds grams of specially activated
charcoal, and 200g of alumina are used as adsorbents. Three
uremic patients have been treated with the 10-liter dialysate
supply system for six months. In clinical studies, several features
of this machine are evident. 1) Although urea reduction rate is
worse than in a single-pass system and postdialysis serum urea
level is high around 80 mg/dl, patients have a good appetite and
develop no gastrointestinal symptoms. 2) Patients do not feel
general fatigue and go to work,comfortably after treatment with
the 10-liter dialysate supply system, though their serum urea
levels remain continuously high around 80 mg/dl. 3) Odor from
the mouth of patients is not detected. 4) Serum potassium tends
to increase but this problem is solved by taking sodium poly-
styrene sulfate or frozen erythrocyte which acts as a potassium
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sponge. 5) Uremic neuropathy, ectopic calcification and itching
are not found.
Automatic machine for dialyzer reuse. A. Albertazzi, G.
Ruggeri, B. Ardizzola, L. Franchini and L. BurzL Nephrology
and Dialysis Dept., S. Orsola Hospital, Bologna, Italy. The prob-
lem of dialyzer reuse and sterilization is still an open one. It
involves clinical, economical and technical problems still under
discussion. A new machine has been designed and assembled in
an attempt to reduce time and cost, maintaining efficiency. The
assembled apparatus includes the following: autoclave; various
fluximeters; audio and video alarms; electronic aspirating, draw-
ing and proportioning pumps and valves. Investigations have
been carried out using coil, parallel flow and hollow-fiber
dialyzers. One thousand dialyses have been checked. Dialyzers
were reused up to ten times. Dialyzer efficiency did not signifi-
cantly reduce. Time saving: the entire procedure for each
dialyzer (washing and sterilization for reuse) did not exceed two
to three minutes. The reduction in cost for each dialysis was up
to 50%. Conclusions: A new machine for sterilization and reuse
of dialyzers is described. It may satisfactorily be employed in
dialysis centers of large acceptance.
Basic distribution of uremic changes and their possible pre-
vention by dialysis. V Bonomini, M. P. Scolarf A. Albertazzi
and G. C. BortolottL Nephrology and Dialysis Dept., S. Orsola
Hasp., Bologna, Italy. A complete statistical study on the appear-
ance and distribution of uremic changes (including calcium
balance, bone biopsies, nerve conduction velocity, glucose up-
take, isotopic and Rx investigations, aminograms, lipid and pro-
tein metabolism, etc.) has been performed in 365 chronic
uremic patients. Basic results. Some lesions were more pro-
nounced in pyelonephritis and polycistic kidney in respect to
glomerulonephritis and vascular nephrosclerosis. With residual
renal function above 40 ml/min, an average 5% of subclinical
changes occurred; with function between 30 and 40, the per-
centage was 16%; between 20 and 30, 22%; between 10 and 20,
31%; and below 10 mi/min, near 100%. Effect of "routine"
dialysis. One hundred thirty-seven patients on RDT have been
followed for up to seven years (serial checks at regular pro-
grammed intervals). Dialysis was not associated with any im-
provement or arrest in the progression rate of uremic changes
when started with percentage of renal function less than 10.
Effect of "earlier" dialysis. In seven patients dialysis was started
when renal function was above 15 mi/mm. After seven years, a
comparative magnitude and progression in all uremic changes
was not found. Conclusions. If the appearance of chronic uremic
changes is to be avoided, the dialysis starting time must be
properly adjusted.
Audiometric changes in cases of chronic renal failure prior
and subsequent J treatment with intermittent hemodialysis.
Muhlis Ozen, Ozkan Sandalci, Ahmet Kadiolu, Münevver
Sandalci and Nurettin Ausolu. Istanbul Faculty of Medicine,
Dept. of Internal Medicine, Capa, Istanbul, Turkey. Audiometric
studies Were carried out before and after treatment in eight
patients suffering from chronic renal failure who were subjected
to intermittent hemodialysis. Hearing was found to have been
affected in all cases at the stage of azotemia showing values
significantly below the corresponding normals. The impairment
was particularly significant in higher frequency ranges, and
following the treatment there was an improvement in hearing
approximately 10 db for the lowest and 20 db for the highest
frequency of the audiometric scale. In addition to these findings,
a narrowing in the bone-air gap was also observed. Determina-
tions of BUN, serum creatinine, uric acid, osmolality, pH, std
bicarbonate, electrolytes, hgb and hct were done before and
after the treatment. As the improvement was reflected mainly
in serum osmolality, BUN and fluid retention, it was thought
that the mechanism reversing the hearing impairment might be
due to the above-mentioned indexes. The narrowing of the bone-
air gap is assumed to be a confirmatory finding.
Microampere electrocution: Unrecognized cause of sudden
death during hemodialysis. Lazaro Gotloib and Ciro Servadio.
Renal Unit and Dept. of Urology, Central Emek Hospital, Afula,
Israel. Sixty cycles' alternate current of 20 microamperes applied
directly to the heart suffice to induce ventricular fibrillation.
Electrical devices such as thermostats and heating elements
present in artificial kidneys are in direct contact with the
dialysis electrolytic bath which is an excellent conductor. Elec-
trical leaks in the dialysis bath can easily pass through a thin
cellophane low-resistance and large-surface membrane, leading
to the myocardium through a blood column low-resistance
pathway. The first report of death because of microampere
electrocution during hemodialysis is presented. A patient on
regular dialysis developed cardiac arrest 40 min after the start of
hemodialysis induced by electric current from a short-circuited
ungrounded thermostat which leads to the myocardium through
the blood column. Danger of electrocution induced by artificial
kidneys is evaluated. Electrical leaks on the microampere range
may be at the origin of many cases of unexplained cardiac
arrest during hemodialysis. Adequate prevention of this kind of
accident is postulated.
Investigation on dlinico-chemical correlations in uremic poly-
neuritis. N. K. Man, G. Cueuille, I. Zingraff, T. Drueke, P.
Jungers, A. Sausse, J. P. Billon and .1. L Funck-Brentano.
Hôpital Necker and Rhône-Poulenc, Paris, France. When ob-
tained on RP 6 dialyzer equipped with polyacrylonitrile mem-
brane, the first dialysate of uremic patients with recent motor
polyneuritis and complete paraplegia due to inadequate dialysis
exhibits a positive correlation on WI 38 cells test and on Charles
River mice test, in comparison to dialysates of patients without
polyneuritis. The dilution of subsequent dialysates for which
the tests give a positive response decreases with time. Simul-
taneously, the clinical symptoms of polyneuritis improve. Among
the fractions obtained by dialysate chromatographic separation,
only those containing 1300 to 1700 mol wt solutes induce a
positive response to the tests. The fractionation of urine
specimens collected from normal subjects shows the presence of
1300 to 1700 mol wt solutes which induce also a positive re-
sponse to the tests but for a much lower dilution. Our first
results show that these two fractions contain polypeptide
solutes. A tentative identification is in process. The rapid clinical
improvement of these polyneuritis patients, in addition to the
dinico-chemical correlations, strengthen the hypothesis of links
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between the body retention of these solutes and uremic
polyneuritis.
Severe hypertension in chronic renal failure: Treated success-
fully with minoxidil. Richard A. Schacht, David Goldstein and
Denis G. Martin. Department of Medicine, University of Louis-
ville, Louisville, Kentucky, U. S. A. Minoxidil, a new oral anti-
hypertensive agent, was effectively used in the treatment of 15
severely hypertensive patients. Eight of these patients had end-
stage kidney disease (four were on chronic hemodialysis [CII]
and four were subsequently treated with CH), two had impaired
renal function, one had renal artery stenosis but bilaterally equal
renin production, one had traumatic aortic dissection and three
had normal renal function. Other antihypertensive agents alone
had been ineffective. Ten patients were treated inhospital. Their
mean pre-minoxidil diastolic B. P. was 130 mm Hg. After four
days of treatment, the mean diastolic B. P. was 93 mm Hg. All
five treated as outpatients showed a similar response. Several
patients have received minoxidil for over one year with excellent
B. P. control. Minoxidil causes a reduction in total peripheral
resistance with an accompanying increase in heart rate and
cardiac output. Because of this, propranolol is effectively utilized
in conjunction with minoxidil therapy. Other side-effects in-
clude hirsutism, as yet unexplained, and sodium and water re-
tention. The latter may be controlled with diuretics or dialysis,
or both. During the past year, 90 patients have been treated
with CII in this center. Many were severely hypertensive yet
none has required bilateral nephrectomy for B. P. control. In
view of our experience with minoxidil, nephrectomy for hyper-
tension control may be unnecessary.
An attempt to prevent B hepatitis in a hemodialysis unit's
team: Utilization of specific immunoglobulins. S. Delons, C.
Naret, C. Ciancioni, A. M Courouce and I. P. Soulier. Centre
Edouard Rist, Paris, France; Centre National de Transfusion,
Paris, France. In a hemodialysis unit, between October 1969 and
April 1974, we have noted 29 cases of hepatitis, for a total of
96 members who have been part of the team. One hundred
thirteen patients have been treated during this period; 60% have
been or are Ag Nb carriers. During the first 18 months, the
team was protected only by the usual asepsis methods. Twelve
cases of hepatitis were noted, for 31 members of the team.
During the next 20 months, 16 cases occurred for a total of 50
members. An injection of specific immunoglobulins was adminis-
tered in cases of overt contamination (18 times). During the last
18 months, protection by specific immunoglobulins has been
performed systematically on all team members who have not
previously contracted hepatitis (38 subjects). Only one case of
hepatitis occurred; it involves a nurse who was no longer re-
ceiving immunoglobulins since antibodies had appeared (retro-
spectively, we consider the titer was insufficient). Contamination
risk seems to have remained constant over the whole period. We
propose to carry on the experiment, with a change in the
periodicity of the injections. We come to two conclusions: In a
hemodialysis unit in which a great number of patients are Ag Hb
carriers, it appears impossible to detect all the circumstances of
contamination for the team; and systematic protection by
immunoglobulins is effective.
Treatment of terminal renal failure due to oxalosis: Case
report and results of a cooperative study of 14 patients. C.
Jacobs, J Rottembourg, L Reach and M Legrain, Hpital La
Pitié Paris, France. A 23-yr-old patient with terminal renal
failure (TRF) due to oxalosis has been treated for 33 days by
peritoneal dialysis and, subsequently, by hemodialysis for ten
months. Main complications have been severe distal ischemia of
the four limbs for which a chronic intravascular coagulation
process is suggested. Amputation of both forefeet was necessary.
Extensive vascular atrophy of the four limbs confined the
patient to bed. Diffuse infiltration of the neuromuscular tissue
by oxalate crystals was seen on biopsy. Complications occurred
in spite of three times seven hours' weekly dialysis with the
Gambro Lundia 13.5 z dialyzer and a daily intake of 9 g of
succinimide. Average blood concentration of oxalic acid before
dialysis was 1861 zg/1O0 ml, and 470 pg/lOO nil after dialysis.
Dialysance of oxalic acid was 80 mI/min. A survey has been
performed using the EDTA registry. Data concerning 14 patients
treated in ten centers in Europe for TRF due to oxalosis have
been collected. Mean survival of the eight patients treated by
dialysis only and alive by January 1974 was 19 months. Four
patients received transplants: one died, one is back on dialysis
and two are alive with a graft functioning for an average duration
of 30 months. From these data, indications and limits of treat-
ment of TRF due to oxalosis are discussed.
Adequate dialysis and immune response. Ervin A. Gombos,
Douglas M. Jefferson and 1. Ganesh B/rat. New York University
School of Medicine, New York, New York, U. S. A. It has been
shown that a dialyzable factor present in uremic sera can sup-
press immune function of normal lymphocytes, and it has been
suggested that cellular immunity is depressed in uremia. We have
examined the possibility that adequacy of dialysis could be
assessed by improvement in immune responses. Uremic buffy
coat cells were resuspended in autologous sera obtained from
uremic subjects prior to and after adequate hemodialysis. The
cells were then stimulated by phytohemagglutinin (PHA), puri-
fied protein derivation (PPD) and streptokinase-streptodornase
(SKSD), and lymphocytic transformation (LT) measured by
[2_14CJ thymidine uptake. The mean thymidine uptake by
PHA-stimulated cells in predialysis sera was 57,844 cpm per
2 X 106 lymphocytes; postdialysis, 17,276 (.70.1%). The mean
predialysis cpm of PPD was 15,750;postdialysis, 3,876 (75.4%).
The mean predialysis cpm of SKSD was 6,117; postdialysis,
3,123 (4O.0%). Lymphocytes from normal controls in dialyzed
uremic sera and cells of hemodialyzed uremic patients (prior to
hemodialysis) had comparable LT with all mitogens, yet dialysis
reduced this response in uremic patients. The predialysis cpm
were restored as uremic indices rose. The cause for this dialysis-
induced phenomenon is unclear. There is good inverse correlation
between dialysis-induced improvement in uremic indices and
thymidine incorporation.
Effects of different dialysis time on some aspects of the
metabolism of carbohydrates and lipids. A. Novarini, U Zuliani,
A. Strata, A. Borghetti and L. Migone. I e II ainica Medica e
Semeiotica Medica, Universit4I Parma, Italy. Nine patients were
dialysed three times weekly for 7 to 12 hr each run with Kill
dialysers and continuous infusion of 10,000 to 16,000 U of
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heparin (prolonged dialysis, PD). Eleven patients were dialyzed
three to four hours every other day with Coil UF2,UF100,
Dasco SP75 and a single shot injection of 5,000 to 8,000 U of
heparin (short dialysis, SD). Dialysate flow was 500 ml/min with
acetate, 35 mEq/liter and glucose, 1 g/liter. In both groups'
NEFA increased and triglicerides (TG) decreased during dialysis.
In the first four hours after dialysis, NEFA decreased andTG
increased. No change in blood glucose and insulin level was ob-
served both during and after dialysis. During PD these was an
initial NEFA increase which was similar to that of SD; then the
concentration remained stable. The fail of TG instead was more
minor than during SD, followed by stabilization. After PD, TG
increased as absolute values and more than SD. The metabolic
effects during dialysis were referred to the lipolitic action of
heparin on neosynthesis of NEFA from acetate: during PD the
continuous infusion of heparin accounts for the stabilization of
values of NEFA and TG; after dialysis there is a lack of heparin-
dependent lipolysis and the TG neosynthesis prevails. The in-
crease of TG after PD is attributable to the higher amount of
acetate given during dialysis. Because of constant insulin and
glucose concentrations, no value should be attributed to glucose
given during dialysis. It may be concluded that both during
dialysis and within a four-hour postdialysis period, SD has an
appreciable effect in lowering the uremic blood concentration
of TG.
New aspects concerning uremia anemia. Heinrich-W. Leber
and Georg Schuitterle. Zentrum für Innere Medizin der Justus-
Liebig-Universitlit Giessen, W. Germany. Though the sufficient
production of protoporphyrin is essential for adequate hemo-
globin synthesis, no information exists about porphyrin meta-
bolism in uremic patients. Therefore, we investigated porpho-
biinogen (PBG) production and uroporphyrin production in
reticulocytes of uremic patients, anemic patients with normal
kidney function and healthy controls. (Enzymes: delta-amino-
levulinic acid-dehydrase and PBG-desaminase). The activity of
delta-aminolevulinic acid-dehydrase in healthy subjects was
40.1 13.5 nmoles of PBG/107 reticulocytes X 60 mm. com-
pared to 8.7 3.7 in uremic patients. PBG-desaniinase in uremic
patients was inhibited in a similar manner. From our results we
conclude that diminished PBG production and disturbed PBG
utilization are important factors in the pathogenesis of uremic
anemia.
Histidine and iron supplementation in dialysis and pre-
dialysis patients: A controlled study. R. Jontofsohn, V. Heinze,
N Katz, U. Stuber, P. Wilke and R. K A. K/ut/ia. Medizinische
Poliklinik der Università't Freiburg, West Germany. Influence of
histidine supplementation on anemia of both patients on RDT
and patients with advanced chronic renal failure (CRF) (crea-
tinine > 6 mg/100 ml) under selective low protein diet (potato-
egg-diet) has been studied by controlled trials. For this purpose
RDT patients with basic medication of i.v. administered iron
(120 mg/week) have been divided into two groups, one with
and one without oral histidine supplementation (3 X 500 mg of
L-histidine/day). CRF patients have been divided into four
groups: 1) without any supplementation, 2) oral histidine sup-
plementation (3 X 500 mg), 3) oral iron supplementation
(3 X 100 mg), and 4) oral histidine (3 X 500 mg) and oral iron
(3 X 100 mg) supplementation. In the RDT patients, histidine
failed to show any influence on anemia. In the CRF trial, there
was a significant increase in hemoglobin concentration (Hgb) in
group 4 after six weeks, with further increase after three
months of treatment. In group 3 the increase in Hgb noted
after six weeks in group 4 was first reached after six months.
Group 2 with only histidine supplementation did not show any
improvement of anemia.
Effect of erythropoietin in normal men and in patients with
renal insufficiency. Ursula Essers, Wiltrud Mill/er and Robert
Heintz. Department Internal Medicine II, Technical University
Aachen, German Federal Republic. Erythropoietin-rich plasma
was obtained by plasmaphoresis from patients suffering from
aplastic anemia. Intravenous infusion of 500 U of erythro-
poietin causes a reticulocyte crisis in normal men and in patients
with slight renal insufficiency (i.e., serum creatinine < 5 mg/
100 ml). Patients with severe uremia needed much higher doses
of erythropoietin ("v 2000 U) to develop reticulocyte crisis.
From these observations in three normal men and 12 patients
with renal insufficiency, it is concluded that erythxopoietin is less
effective in severe uremic intoxication. However, there is no
absolute resistency to erythropoietin even in terminal uremia.
Renal transplantation in the vely young child. S. M Mauer,
C. M. K/el/strand, T. 1. Buselmeier, R. L. Simmons and 1. S.
Na/arian. University of Minnesota, Minneapolis, Minnesota,
U. S. A. Thirteen children, ages 1 to 5 years (mean, 3.5 years),
were transplanted in the last four years and 11 are alive with a
mean follow-up of 1.9 years. The indications for transplantation
were unique when compared to adults; five had congenital
nephrotic syndrome (CNS), five had dysplastic-hypoplastic kid-
neys and one each had polycystic kidneys, nephroblastoma and
glomerulonephritis. One child died of peritonitis following cor-
rection of artery stenosis in a cadaver kidney and a 1-year-old
died following rejection of his mother's kidney. The 11 survivors
initially received related donor transplants. Two children re-
quired retranspiantation, one receiving a cadaver graft. The
serum creatinine of the 11 survivors is 0.67 0.23 ( SD)
mg/100 ml. Weight has increased from 10.1 2.3 kg (range, 6 to
13 kg) to 15.2 6.3 kg. Growth has been excellent with a mean
height of 32.3 4.7 inches before transplantation increasing to
38.1 5.5 inches. Nine of 11 chlldren have grown at rates
greater than expected for their ages (P < 0.005) while receiving
1/3 mg/kg of prednisone/day. These children have also shown
remarkable catch-up in psychomotor function. Complications
have included the loss of an arm in one child and urinary tract
infections requiring removal of a refluxing autogenous ureter in
another. Overall, our results in this young age group are better
than in any group of patients we have studied. Thus, we con-
clude that related donor transplantation is the treatment of
choice for renal failure in children having reached 1 year of age,
and6 kginbodywt.
Survival and "true" rehabilitation after dialysis and trans-
plantation: A seven year follow-up. V. Bonomini, A. Vangelista,
A. Albertazzi and S. StefonL Nephrology and Dialysis Dept., S.
Orso/a Hosp., Bo/ogna, Italy. In order to evaluate the exact
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magnitude of the survival/rehabilitation ratio due to dialysis or
transplantation (rehabilitation: disappearance of all "uremic"
changes), a critical evaluation of computer recording checked
data (six months to seven years) in 38 transplanted patients and
137 on RDT has been made. Memorized indexes included bone
biopsies, nerve conduction velocity, glucose uptake, isotopic and
Rx investigations, protein and lipid metabolism, etc. Dialysis. In
all the survivors, RDT did not induce any "rehabilitation", when
started with Cr. Cl. below 10 mi/mm. Dialysis, however, was
able to prevent the appearance and the progression of the lesions
when started earlier. Transplantation. A complete "true" re-
habilitation has been found in 33 patients after 6 to 11 months
and in 7 patients after one year. Bone resorption was the last of
the changes to disappear. Survival/rehabilitation ratio was mark-
edly influenced by the nature of the responsible renal lesions.
The poorest results occur in glomerulonephritis. Conclusions.
Dialysis does not "rehabilitate" chronic uremic patients. Uremic
lesions may be prevented by "earlier" dialysis. A complete "re-
habilitation" occurs after renal transplantation, where the still
too low survival/rehabilitation ratio may be influenced by
several presently known factors.
Resolution of secondary hyperparathyroidism after cadaveric
renal allograft. Z Varghese, M. R. Wills, K. Y. Ahmed, K A.
Baillöd, G. L. V. Tatler, I. P. Hopewell and J F. Moorhead.
Royal Free Hospital, London, EnglanL In 24 patients, we have
studied some biochemical (calcium, phosphate, magnesium, alk.
phosphatase, plasma hydroxyproline, immunereactive parathy-
roid hormone [i-PTHJ, total protein and albumin, creatinine
clearance) and radiological indexes before transplantation, while
they were on maintenance hemodialysis and after renal trans.
plantation. None of the patients were taking aluminum hydrox-
ide gel after transplantation. Radiological survey before trans-
plantation showed the following features: normal (9), erosions
(4), fractures (6) and calcification (5). Sensitive biochemical
indexes such as plasma hydroxyproline and i-PTH were signifi-
cantly higher in all patients with radiologically recognizable
lesions when compared with normal patients. With improvement
in renal function, the erosions healed; serial biochemical moni-
toring from 0 to 60 months showed progress towards normality
with respect to plasma calcium, hydroxyproline and i-PTH in all.
In two patients with chronic rejection and inadequate renal
function, plasma hydroxyproline and i-PTH returned to ab-
normal concentrations. Patients with adequate renal function
after renal transplantation recovered from the manifestations of
secondary hyperparathyroidism within the first few months
after transplantation.
Circadian rhythm of plasma renin and aldosterone after renal
transplantation. IL Armbruster, W. Vetter, C. Uhlschmid, K.
Z4ruba, R. Beckerhoff and W. Siegenthaler. Departments of In-
ternal Medicine and Surgery, University of Zurich, and Hemo-
dialysis Unit, Stadtspital Waid, Zurich, Switzerland. In normal
supine man, ream and aldosterone are secreted episodically with
a marked circadian rhythmicity similar to that of cortisol. The
rhythm of plasma renin activity (PRA) and plasma aldosterone
(PA), however, persists when pituitary ACTH is suppressed. To
evaluate the role of renal innervation, PRA and PA were
measured in five renal aiiograft recipients. Hormone determina-
lions were performed at short-term intervals from 8 PM to 8 AJvf
during constant recumbency. Four normal subjects were tested
in the same way. Contrary to normal controls, which showed
significant differences between low hormonelevels in the evening
and high values in the morning (P < 0.001), no significant varia-
tions of PRA and PA were observed in the patients with a trans-
planted and, thus, denervated kidney. These data suggest that
intact renal innervation is necessary for the normal circadian
rhythmicity of basal renin release and, indirectly, for that of
adrenal aldosterone release.
Urinary acidification in renal allograft G. Graziani, A. De
Vecchl and C PonticeilL Sezione dl Nefrologia, Ospedale
Policlinico, Milano, Italy. Urinary acid excretion was measured
in 15 recipients of human renal allograft during rejection
episodes. We found a decrease of more than 40% in renal net
H (ammonia plus titratable acid minus bicarlonate) excretion
in 14 patients. In seven patients impairment of urinary acidifica-
tion was noted before any increase in blood creathiine concen-
tration. No patient showed early significant variation in blood
pH and C1. Nonexcreted acids were probably buffered by
intra- and extracellular buffers. Improvement of creatinine clear-
ance after therapy was accompanied by H' excretion higher
than before rejection, perhaps on account of acid accumulating
during the episode. Only one, out of 15 transplanted patients
without signs of rejection, showed a significant impairment of
urinary acid excretion. This acid-base imbalance may be due
either - to the reduction of renal blood flow, which is present in
rejection, or to the ischemia of peritubular vessel caused by
immunoglobulin deposits. This early and frequent impairment
of Ht excretion can support the diagnosis.
Evaluation of chlorpromazine pretreatment of donor kidneys
in the Copenhagen group. JØrgen I. Dahlager, Torben Bilde and
Hans Løkkegaard. Rigshospitaler, Copenhagen, Denmark. -Necro-
kidneys damaged by ischemia often show a late onset of function
or fall to regain function. The effect of pretreatment with
chlorpromazine on renal function has been investigated. Measure-
ments of the vascular resistance during cold perfusion have
shown that chlorpromazine pretreatment of rabbit kidneys
exposed to varying duration of warm and cold ischemia de-
creases resistance, an effect more pronounced the longer the
duration of warm ischemia. The effect persists after 24 and
48 hr of cold preservation. No effect was shown on the tubular
function as measured by 1251-Hippuran uptake in cortex slices
from kidneys exposed to similar ischemia; but 1251-Hippuran
renography showed a clear improvement in kidney blood flow
after ischemic damage, when the animals were pretreated. In
experiments with temporary clamping of the renal artery and
contralateral nephrectomy, chlorpromazine pretreatment results
in earlier onset of renal function and improved survival. The
same effect has been shown in transplantation of pigs with
kidneys exposed to 1 hr of warm ischemia and preserved 24 hr at
+40 C. These results encouraged us to try chlorpromazine treat-
ment of human necrokidney donors. Pretreatment has improved
onset of function after transplantation. The number of immediate-
functioning kidneys in the pretreated and untreated group was
85 and 56%, respectively. We conclude that chiorpromazine has
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an effect on the renal vascular system which in turn facilitates
reestablishment of kidney function after transplantation.
Changes of renal ATFase enzymes in different typesof kidney
preservation. M J Varkarakis, D. Papahad/opoulos and G. P.
Murphy. Roswell Park Memorial Institute, Buffalo, New York,
U S. A. A relationship seems to exist between the (Na + K) —
ATPase enzyme and the sodium pump link process, both of
which can be affected during hypothermic storage of kidneys.
The enzymatic renal changes of total (Na + K) + Mg — ATPase,
(Na + K) — ATPase and Mg — ATPase were examined in kidneys
preserved for 24 hr at 4 to 8°C and stored in 1) Ringer's lactate
solution; 2) Ursol solution (same as C3 Cohn's solution with a
decrease in magnesium sulfate concentration); and 3) Ursol solu-
tion (which has decreased potassium content). The data were
compared with unstored kidneys. It was found that storage in
Ringer's lactate decreased both cortical enzymes (P < 0.05).This
was not the case with kidneys stored in Ursol solutions (second
group) (F> 0.5). However, the third group of stored kidneys
had a decrease of the cortical (Na + K) — ATPase enzymes.
Medullary enzymatic changes were similar in all stored kidneys.
These changes were a decrease of total (Na + K)+ Mg — ATPase
and of Mg — ATPase and a normal (Na + K) — ATPase. Thus,
cold preservation of kidneys by extracellular solutions decreases
all cortical ATFase enzymes, while the intracellular solution,
Ursol, minimizes that effect. It appears that the decrease of Mg
concentration of the Ursol solution does not detectably affect
cortical enzymes, while the decrease of potassium concentration
decreases the (Na + K) — ATPase cortical activity. We conclude
that changes of ATPase enzymatic systems can be a factor ex-
plaining the different results seen in clinical or experimental
renal preservation using extracellular or intracellular type solu-
tions. These changes could be related to the ischemic injury of
preservation.
Functional evaluation of renal transplants by computerized
double or triple isotope scintigraphy and subsequent clearance
measurements. K M6hring, L Röhl, J. Clorius, K Dreikorn and
H. W. Schüler, Depart. of Urology, Surgical Centre and Cancer
Research Centre, Heidelberg, Federal Republic Germany. To gain
simultaneous informations about regional graft perfusion (RGP),
tubular function (ERPF), glomerular filtration rate (GFR) as
well as size and urinary drainage of the transplant, 50 zCi/kg or
99m-Tc04 was injected for study of RGP followed by simultan-
eous injection of 5 MCi/kg of l3zJorthojodohippurate (for
ERPF) and 1111n-DTPA (for GFR) each for subsequent double
isotope sequential scintigraphy and measurement of ERPF and
GFR by means of infusion clearance. 1111n-marked fibrinogen
was injected if RGP, GFR an4 ERPF were indicating rejection.
1111n-fibrinogen uptake of the graft could be visualized by use
of the scintillation camera. The increased plasma disappearance
rate of 1111n-fibrinogen could be subsequently quantitated by
the infusion clearance method. The analysis of ten cases shows
that 99m-Tc04 images can clearly demonstrate the patency of
the renal artery and its branches. In conjunction with ERPF and
GFR values this forms the basis for follow-up studies. Acute
tubular necrosis can be differentiated from early rejection by
successive application of 99m-Tc04 and the combination of
1111n-fibrinogen and 131J-o-JHA with subsequent clearance
measurements.
Les complications pulmonaires des transpiantes renaux. F.
Vereerstraeten, I. Vereerstraeten, I. P. Dc Koster, P. Kinnaert
et C. Toussaint. Départements de néphro logic et de pneumologie,
Service de Médecine et de Chirurgie, Hpital Universitaire
Brugmann, Bruxelles, Belgique. Quatre-vingt complications pal-
monaires (oedIme pulmonaire exclu) ont observes chez 67
transplants, sur un total de 173 greffes pratiqu6es de 1965 a
1973. L'agent causal est une bactérie dans 60%, une mycose
dans 6%, un cytomégalovirus dans 12%, le pneumocystis carinii
dans 8% et une embolie dans 14% des cas. Une relation étroite
avec un rejet est notée dons prs de 70% des cas. Les infections
mycotiques et virales ont le pronostic Ic plus sévre: cUes
entrainment Ic décbs dans prs de 100% des cas. Les infections
bactériennes, mycotiques, virales et les embolies apparaissent au
cours des six premiers mois de Ia transplantation, dans 65% des
cas; l'infestation pneumocystis survient plus tardivement. Les
meth6des les plus efficaces pour établix le diagnostic sont les
biopsies pleurale et pulmonaire (chirurgicale), les ponctions
pleurale et trachéale, l'hémoculture et le virage du titre des
anticorps sfriques. Le traitement spcffique est efficace dans
60% des infections bact&iennes et dans 50% des embolies et des
infestations k pneumocystis; par contre, il est peu utile dans les
infections mycotiques et totalement inoprant contre le cyto-
mgalovirus.
Comparison of urinary excretion of NAG (N-acetyl-(3-D-
glucosaminidase) and FDP (fibrin degradation products) in the
early diagnosis of renal graft rejection. B. Garcia, S. M. Tucker,
A. E. Thompson and A. .1. Wing. St. Thomas' Hospital, London,
England. Determinations of urinary NAG and FDP have both
proved useful in the early diagnosis of graft rejection. In this
study we have compared the results of simultaneous measure-
ments of NAG and FDP in a group of 45 renal transplant re-
cipients. NAG was estimated by the flurometric methods
previously described and FDP by hemaglutination-inhibition-
immuno-assay. Simultaneous measurements were made daily on
17 patients in the immediate posttransplant period, and at
intervals in 28 patients transplanted 3 to 48 months beforehand.
Episodes of graft rejection were accompanied by a parallel rise
in NAG and FDP. The measurements showed a significant
correlation (P < 0.001). Both tests were therefore equally useful
in the early diagnosis of rejection. NAG was elevated but FDP
was not when the nephrotoxic antibiotic gentamicin was given.
Both were high if ATh had occurred in the graft. The measure-
ment of NAG is the quicker and less laborious test and we
therefore recommend it for the routine surveillance of trans-
planted patients. In certain circumstances, it may be useful to
perform both tests.
A modified rosette Inhibition test in the early diagnosis of
renal allograft rejection. A. Cantaluppi, C. Ponticelli and G.
Fiorelli Sez. di Nefrologia, Ospedale Foliclinico and Instituto
di Patologia Medica, Milano, Italy. The clinical value of the
Rosette Inhibition Test, introduced by Munro (1971), is still
controversial. The test depends on the ability of antilymphocyte
globulin (ALG) to inhibit spontaneous rosette formation by
peripheral I lymphocytes in contact with sheep red blood cells.
A modification of the technique, which permits highly accurate
marking of the T cells, was applied to follow the progress of 28
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patients with renal allografts, making two or three determina-
lions/week from the day of transplantation for at least two
months. The "inhibition concentration" — that is that concen-
tration of ALG causing 25% inhibition of rosette formation —
was significantly increased in 26 of 27 separate determinations
made two to five days before rejection became clinically evident,
and in only 21 of 260 determinations after which no clinical
evidence of rejection developed. The results indicate that this
modified test is a useful tool for the follow-up of transplanted
patients either to predict the occurrence of or to confirm the
diagnosis of rejection.
A simple test for early detection of severe renal homograft
rejection. R. Oppoizer, Cli. Leithner, A. Wolf, W. Fin ggera and
H. Stummvoll. 2nd. Med. Dept., University of Vienna, Austria.
Serial examination of urinary titrable acidity after renal homo-
transplantation showed that out of 18 acute rejection episodes,
one-third was preceded by spikes of high acid output 24 to 48 hr
before serum creatinine increased and clinical symptoms became
apparent. For detection of rejection-associated spikes of acid
excretion, a rapid and sensitive test was developed. It is based on
the fact that coagulation of fibrinogen is prolonged at acid
values under pH 5. There can be demonstrated a good correlation
between prolongation of the thrombin-coagulation time and
raising amount of titrable acidity of the urine portion added to
the fibrinogen solution in our test system. The fibrinogen solu-
lion is-rendered incoagulable when acid excretion becomes un-
usually high before an acute rejection episode. In one case we
could observe an jsrine acid spike before an acute rejection
episode appearing three months after renal homotransplantation.
A concomittant excretion of FDP in urines of high titrable
acidity was not observed. Thus, serial estimation of titrable
acidity by a rapid test is of value in the early diagnosis of rejec-
tion episodes. It is a good supplement to the serial determination
of FDP excretion.
Proteinuna as a diagnostic marker after human kidney trans-
plantation. W. H. Boesken, M. Schmidt, R. Jontofsohn and V.
Heinze, Med. Klinik u. Foliklinik, Freiburg, B R D. Molecular
weight analysis of urinary proteins in 30 patients following
cadaveric kidney transplantation was carried out using poly-
acrylamid electrophoresis with detergents in order to distinguish
complications to the transplant. In general this method differen-
tiates proteinurias according to the protein's origin from the
nephron: Macromolecules result from glomerular damage, while
micromolecular proteinurias (mol wt 10,000 to 70,000) are in-
dicative of tubular diseases. For 20 days after transplantation a
tubular form was found; recurrence of such proteinuria was
always associated with rejection crises, either transiently in acute
rejection or as a permanent finding in observations of chronic
rejection. A different tubular proteinuria (mol wt 40,000 to
70,000) was found during clinically normal periods after trans-
plantation. The recurrence of permanent glomerular proteinuria
was seen in nine patients; in one a recurrent glomerulonephritis
was histologically confirmed and different stages of glomerular
proteinuria were observed. In four patients this pattern may be
caused by glomerular rejection disease. Following steroid treat-
ment for rejection in six patients all macromolecules, even the
physiologically filtered albumin, disappeared from the urine
despite persisting tubular proteinuria. Disc-electrophoretio pro-
tein analysis has proved to be a valuable tool in distinguishing
posttransplantation complications, especially since changes in
urinary protein excretion often precede the overt clinical
symptoms.
Humoral and cell mediated immunity after clinical trans-
plantation. Erik Arnesen, Helge Bondevik and Erik Thorsby.
Tissue Typing Laboratory, Rikshospitalet University Hospital,
Oslo and Renal Unit, Dept. VII, Ulleval Hospital, Oslo, Norway.
Long-term survival of allografted kidneys suggests immunological
adaptation toward transplantation antigens on the aliografted
kidney. Ten patients grafted with a kidney from a living related
donor, of which nine had a well functioning graft two to ten
years after grafting, were examined with the complement-
dependent cytotoxicity (CDC) test, T cell-mediated lympholysis
(CML) test, antibody-induced cell-mediated cytotoxicity (AICC)
test and inhibition of mixed lymphocyte culture (MLC) tests.
No direct CML was demonstrated. Sera from two of nine patients
with functioning kidneys were positive in AICC test against
donor cells and also gave specific MLC inhibition. A nonspecific
reduced response of MLC by autologous serum as compared to
normal serum was seen in seven patients, possibly due to the
effect of immunosuppressive drugs. Specific antibodies against
donor could not be demonstrated in serum from the patient who
had rejected the kidney. We conclude that human kidney trans-
plants may function normally in spite of persistent specific anti-
donor antibody response. Furthermore, the lack of detectable
Tcell-mediated cytotoxicity against the donor may be significant
in relation to the outcome.
Minimizing the risks of treating acute allograft rejection.
Robert R. Siegel, H. C Aquino, R. G. Luke and RaeDene
Schmidt. Renal Medicine Division, Univ. of Kentucky Med. Ctr.
and VA Hosp., Lexington, Kentucky, U S. A. The risks of treat-
ing allograft rejection are primarily related to high-dose steroid
therapy and nearly outweigh the advantages of óadaveric trans-
plant over regular hemodialysis. We should be able to determine
when the possible benefit of antirejection therapy may not
justify the risks, but the literature offers no consensus on how
the determination can be made. We therefore analysed 20 severe
acute rejection (SAR) episodes for indices of reversibility. SAR
occurred in 6 of 24 live donor and 6 of 18 cadaveric allografts
on standard azathioprine-prednisone regimen to prevent rejec-
tion. Renal function pre-SAR was similar in all patients. Ccr fell
to 10 mi/mm or less, but degree of renal dysfunction was not
predictive of reversibility, nor were time since transplant,
oliguria/anuria, proteinuria, Na retention, hypertension or graft
pain. The only consistent finding was that function began to
improve in reversible rejection 3.8 1 days after beginning
therapy. Our rejection treatment protocol, based on this finding,
is to treat confidently diagnosed acute rejection with high
steroid dosage for five to seven days, then biopsy nonresponders.
Among 37 patients treated for 57 rejection episodei, there was
no G.I. hemorrhage, no fatality and only 12 serious infections.
Strict limitation of the period of high-dose steroid therapy is
attended by reduction of morbidity and mortality in renal
allograft patients. Delayed biopsy forestalled removal of salvag-
able grafts.
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Delayed excretion of conjugated suiphamethoxazole in
uremia. Lazaro Gotloib, Miguel Mines, Ciro Servadio and
Ricardo Kohan. Renal Unit and Dept. of Urology, Central Emek
Hospital, Afula, Israel. Previous reports about renal handling of
free suiphamethoxazole in uremia are contradictory. Data on
blood persistence of total (free and conjugated) suiphamethox-
azole are lacking. Our study was carried out in nine chronic
uremic patients and in five normal controls. Free and total
suiphamethoxazole blood concentrations were detennined with
the Bratton-Marshall technique after a single oral load of 1 g.
Twenty-four hours after maximal absorption blood concentra-
tions of free sulphamethoxazole in uremic patients ranged
between 0.75 and 2.75 mg/tOO ml (mean value, 1.71 mg/100 ml),
whereas in normal controls values ranged between 0.45 and
1.70 mg/100 ml (mean value 1.09 mg/100 ml). The difference
was not statistically significant (P > 0.1). At the same time
blood concentrations of total sulphamethoxazole in uremic
patients ranged between 3.90 and 7.50 mg/100 ml (mean value
6.31 mg/100 ml), whereas in normal controls blood concentra-
tions between 1.25 and 2.95 mg/100 ml (mean value, 2.17 mgI
100 ml) were found (P < 0.001). Twenty-four hours after the
peak level persistence of total sulphamethoxazole was 88.08% in
uremic patients and 22.8% in normal controls (P < 0.001). We
conclude that in uremia, low blood concentrations of free
sulphamethoxazole do not indicate that the dose can be in-
creased. High levels of accumulated acetylated drug may cause
serious toxic effects. Use of this drug in renal failure must there-
fore be reevaluated.
Uremic waste recovery: Ill. Additional clinical trials. Kai
Setiilñ, Helvi Heinonen and hone Schreck-Purola. 1st Dept. of
Pathology, University of Helsinki, Finland. Following our idea
(e.g., in Proc. Conf E.D. TA. 9:514, 1972), clinical trials on
uremics revealed that it is possible to alleviate progression of
uremic symptoms by oral administration of certain lyophilized
soil bacteria (SB) (IRCS 1, 35, 1973). SB therapy affected both
blood creatinine and urea concentrations; the maximum crea-
tinine decrease was 30%, urea%, within about 14 days. Thus,
even the blood creatinine concentration can be affected by
conservative means. The in vitro and clinical studies have been
continued. No side-effects developed in a continuous treatment
period of 12 months. Prolonged SB therapy apparently further
decomposes such, so-far unidentified NPN "urotoxins" which
may have hypertensive effects: it was possible to decrease the
dosage of the antihypeitensive compound practolol down to
1/50 to 1/100 from the initial dosage. The possibilities of SB
therapy will be outlined in detail.
Adaptations in metabolic acidosis: A reinterpretation. Ed-
mund Bourke and Jane Oliver. Dept. of Medicine, Trinity
College, Dublin, Ireland. The concept that increased ammonia
secretion in acidosis results in increased H excretion derives
from the practice of writing the formula of glutamine in the
unionized form. At physiological pH, glutamine is ionized, gives
rise to NH not NH3 and does not result in elimination of
H. An alternative interpretation is needed. Following oral HQ
to rats on a constant nitrogen intake, the enhanced ammonium
excretion is coupled with an equimolar decrease in urea produc-
tion falling by 32% of control values. NH4HCO3 administration
did not alter urinary ammonium but was recovered as urea. By
contrast, following NH4CI, only 15% of the increased nitrogen
load was recovered by urea, the remainder being accounted for
as urinary ammonium. Argwnents will be presented to support
the following interpretation. Amino nitrogen is ordinarily con-
verted to urea. Each turn of the urea cycle utilizes two bicar-
bonate ions. The subsequent metabolism of the remaining
carbon skeleton generates bicarbonate. In HCI acidosis, waste
nitrogen bypasses urea synthesis to be excreted as NH. No
bicarbonate is utilized but the carbon skeleton still generates
bicarbonate. The HCO produced from conversion of NH4HCO3
to urea is balanced. Urea formation from NH4C1 utilizes net
HCO. The consequent acidosis causes a shift in disposal of
waste nitrogen of amino acids from urea to urinary NH —
with generation of HCO.
Middle Molecules in uremia. P. Fiirst, H. Asaba, A. Gordon
and 1. Bergstr6m. St. Erikt Hospital, Stockholm, Sweden. There
is evidence that substances in the range of mol wt 500 to 3000
are uremic toxins. We have developed a high speed gel filtration
technique which enables us to separate biological material
(serum, urine, dialysate) into ten u.v. absorbing peaks. With this
technique more than 400 samples from 50 uremlc patients and
from normal subjects have been analyzed. One peak in the
middle molecule range (approx. 1300) is present in uremic
serum but not in normal serum. It is also prominent in peritoneal
and hemodialysate, normal urine and uremic urine. A quantita-
tive decrease in this peak (peak in serum accompanied dietary
treatment, hemodialysis and peritoneal dialysis. The dialysis
characteristics are consistent with a middle molecule configura-
tion. Using gradient eluation on DEAE-sephadex with a buffer
solution of increasing ionic strength, peak 7 can be separated
into seven to eight peaks. The relative absorbance of these peaks
varies with the clinical situation (acute renal failure, pericarditis,
chronic renal failure, dialyzed patients, etc.). In one patient
undergoing renal transplantation from a living donor, the most
prominent of these peaks was totally absent from the serum one
day after transplantation. In conclusion, middle molecule pep-
tides accumulate in serum from uremic patients and their con-
centration seems to be related to the presence of uremic
symptoms.
Inhibition of DNA synthesis by guanidine compounds in
uremia. G. Ku, V. M. Hird, Z. Varghese, K. 1'. Ahmed and 1. F.
Moorhead. Royal Free Hospital, London, England. Uremic
patients are known to have impaired cellular immunity, and
lymphocytes from these patients may exhibit decreased in vitro
reactivity to mitogens. Uremic plasma has also been shown to
have an inhibitory influence on transformation of lymphocytes
in vitro. Methylguanidine has been shown to cause uremic mani-
festations when administered to dogs and it is known to accumu-
late with other guanidine compounds in the plasma and tissues
of uremic patients. The effects of these substances on in vitro
lymphocyte reactivity have not been fully investigated. We
therefore studied four guanidine compounds — methylguanidine,
guanidine hydrochloride, guanidinosuccinic acid and guanido-
acetic acid in relation to the degree of 3H-thymidine incorpora-
tion of phytohaemoagglutinin (PHA)-stimulated peripheral
blood lymphocytes from healthy volunteers as in index of in
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vitro DNA synthesis. Of the four compounds studied, methyl-
guanidine and guanidine hydrochloride had a dose-dependent
inhibitory effect on PHA-stimulated in vitro DNA synthesis in
normal human lymphocytes. The relevance of this finding to
cellular immunity in uremic patients will be discussed.
Alteration of hepatic acetylation in uremia. Adrian Fine and
David Sumner (Intr. by A. C. Kennedy). Renal Unit, Glasgow
Royal Infirmary and Dept. Materia Medico, Stobhill General
Hospital, Glasgow, Scotland. This study was undertaken to ex-
amine hepatic detoxification in uremia. The rate of acetylation
of suiphadimidine was estimated in 25 normal subjects and in
two groups of dialysis patients with a serum creatinine of
> 7 mg/i00 ml for at least one yeas prior to intermittent hemo-
dialysis. Group A consisted of nine randomly selected patients,
four of whom were about to commence dialysis and five who
had been dialyzed for less than one year and Group B consisted
of seven patients dialyzed for between one and six years. The
metabolic clearance rate after a 2 g oral dose of sulphadimidine
was derived from the area under serum concentration curve vs.
time. In Group A, eight patients (88%) were "fast" acetylators,
compared with 32.1% of a normal population (P < 0.001). In
Group B, only one patient was a "fast" acetylator (P> 0.05).
The results demonstrate that hepatic acetylation is altered in
chronic uremia and that intermittent hemodialysis of greater
duration than one year appears to alter this trend. These varia-
tions in pharmacokinetics should be considered when adminis-
tering drugs in uremia which are significantly metabolized by
the liver. This previously unrecognized alteration in hepatic
metabolism may indicate an important compensatory role for
the liver in uremia.
Skeletal lesions and calcium metabolism in early renal failure.
IL IL Malluche, E. Ritz, M. Hodgson, A. Gati, W. Krause and
H. P. Lange. Universitiitskliniken Frankfurt/m.u.Heidelberg, W-
Germany. Fifty patients in early and advanced renal insufficiency
(GFR, 100-10) were studied. Serum PTH (radioimmunoassay),
ionized serum Ca, U x V Ca., Cp/Ccr, urinary OH-proline and
bone biopsy (lilac crest; undecalcifled sections, micromorpho-
metric measurements) were evaluated. Findings. In patients with
GFR < 60 mi/mm, a rise of serum PTH (unrelated to serum
calcium), an increase of Cp/Ccr, an increase of urinary OH-
proline and — in some patients correlating with the severity of
bone histology — a fall in (Ca) were observed. Quantitative
bone histology showed an increase of osteoclastic surface re-
sorption (95.8 46.0 mm2/cm3; normal: 65 50.9) and endos-
teal fibrosis at a serum creatinine concentration of 3.0 mg/i 00 ml.
In some, however not in all patients, an increase of volumetric
density of osteoid (2.71 3.62; normal; 0.729 0.96%) and
mean osteoid seam thickness (17.9 10.8; normal: 8.81 11.0 Lg)
were observed. Impaired mineralization in these patients could
also be demonstrated by tetracycline-double-labelling. Conclu-
sion. Serum chemistry and bone histology is abnormal in early
renal failure. Both fibroosteoclasia and impaired mineralization
can be demonstrated.
Homeostasis and action of parathyroid hormone in normal
man and patients with mild renal failure. S. G. Massry, F. Llach,
F. R. Singer, K Kurokawa, J. II. Kaye and J. W. Coburn. Depts.
Med., Cedars-Sinai Med. Ctr., VA Wadsworth Hosp., and UCLA
Sch. Med, Los Angeles, California, U S. A. Secondary hyperpara-
thyroidism and skeletal resistance to exogenous parathyroid
hormone (PTH) occur in chronic renal failure, but the time of
their appearance in the course of renal disease remains uncertain.
This study evaluates recovery from acute hypocaIcemia induced
by EDTA infusion in ten normal subjects (N) with creatinine
clearances (GFR) of 115 6 mI/mm, and 13 patients with mild
renal failure (MRF), GFR, 66 6 ml/min. Nonchelated serum (S)
Ca, immunoreactive PTH (iPTH) and urinary cyclic AMP
(UcAMP) were measured before and serially after EDTA. As
SCa fell from 9.6 .12 to 6.4 14 mgflOO ml and from
9.5 .17 to 5.8 .08, iPTH rose from <0.15 to 0.37 0.06
ng/ml and 0.33 0.06 to 1.03 0.28 in N and MRF, respective-
ly. Then, SCa rose, but more slowly in MRF than N despite per-
sistently higher iPTH in MRF. In MRF and N, UcAMP rose
from 2.52 0.60 and 2.22 0.18 n moles/mm to 5.49 .14 and
7.80 1.8, respectively. These data indicate that secondary
hyperparathyroidism occurs in mild renal failure, with higher
basal iPTH and greater PTH response to hypocalcemia. in both
N and MRF, UcAMP increased, suggesting renal response to in-
creased endogenous PTH. Delayed recovery from hypocalcemia
in MRF despite higher iPTH levels indicates the existence of
skeletal resistance to PTH, a factor which probably contributes
to genesis of 20 hyperpaxathyroidism in renal failure, even early
in its course.
Parathyroid hormone (PTH) metabolism in chronic renal
disease. K. Hruska, R. Kopelman, W. E. Rutherford, S. Klahr and
E. Slatopolsky. Renal Division, Washington University, St. Louis,
Missouri, U S. A. These studies were designed to evaluate the
role of the kidney in the metabolism of PTH and the 1-34 amino
acid fragment of the hormone. Studies were performed in seven
normal and six uremic dogs after administration of bovine PTH
(b-Pm) or synthetic 1-34 (S1-34). Bovine PTH and synthetic
1-34 were determined by radioimmunoassay using two different
antibodies. Total metabolic clearance rate (MCR), determined
by standard methods, averaged 98 ml/min for b-PTH and
311 ml/min for S1-34. Uremia decreased total MCR by more
than 60%. Renal clearance of b-PTH was 61 mI/mm and
114 ml/min for S-1-34. Uremia decreased the renal clearance of
b-PTH to 13 mI/min and the S1-34 to 26 mI/mm. The t% of PTH
was prolonged after the development of renal insufficiency.
These studies indicate that the kidney metabolizes a large pro-
portion of both intact b-PTH and S1-34. Uremia decreases the
total MCR of b-PTH and Si-34 by decreasing their renal clear-
ance. No evidence for increased extrarenal metabolism of b-PTH
or S1-34 was found in uremia. These results suggest that de-
creased renal metabolism of b-PTH and S1-34 may be in past
responsible for the elevated concentrations of the hormone and
its fragments seen in chronic renal disease.
A test for parathyroid suppressibility in renal osteodystrophy.
J. F. Moorhead, Z Varghese, G. Ku, R. A. Baillod, A. I. Sweat-
man, G. L. V. Tatler and M. R. Wills. Royal Free Hospital,
London, England. Various forms of calcium infusion tests have
been used in the past to test the suppressibility of the para-
thyroid glands. Because of the sensitivity of plasma hydroxypro-
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line as an index of collagen turnover rate and the osteoclastic
response to parathyroid hormone, we have tested the adequacy
of using plasma hydroxyproline in monitoring response to an
acute calcium infusion. Fifteen mg of calcium/kg of body was
infused over a four-hour period in 12 patients. Four patients
were studied before the start of the dialysis treatment and the
rest were on hemodialysis for varying periods of time. Calcium,
phosphate, proteins and hydroxyproline were measured at zero,
one, three, four, five and seven hours after the start of the in
fusion. In five patients calcium infusion resulted in a significant
reduction in plasma hydroxyproline and in the other seven only
minimal changes. All the 12 patients were dialyzed against a
calcium concentration of 7.5 mg/100 ml and alter six months
four of the five patients who had significant reduction in plasma
hydroxyproline showed radiological improvement. Three of the
seven nonresponders required parathyroidectomy. This test has
been used successfully over the last year to institute appropriate
forms of treatment for the renal osteodystrophy.
The investigation and treatment of renal osteodystrophy.
G. R. D. Catto, M. MacLeod, B. PeIc and E. Kodicek. Depart-
ment of Medicine, University of Aberdeen, Dunn Nutritional
and Strangeway 's Research Laboratories, Cambridge, United
Kingdonz Investigation of renal osteodystrophy has been delayed
by the absence of a sensitive method for detecting in vivo small
changes in the calcium content of bone. A new technique has
been developed to measure specifically the calcium content of a
hand by neutron activation analysis; this seems a more sensitive
indicator of the rate of change in the calcium content of bone
than skeletal radiography or photon absorption. Seventeen
patients on maintenance hemodialysis have been studied for a
period of 24 months. The magnesium concentration of the
dialysate was increased to seven of the patients. The rise in
serum magnesium concentration thus produced did not de-
crease the rate of skeletal demineralization. Calcium carbonate
was administered orally to seven patients. The rate of deminer-
alization was slowed in all and an increase in the calcium content
of bone was detected in five patients. 1-alpha hydroxycholecal-
ciferol, a synthetic analogue of 1, 25-dihydroxycholecalciferol
was administered to three patients in a dose of 2 g/day orally.
In all three patients absorption of calcium from the gastrointes-
tinal tract and skeletal calcium content were increased. It is con-
cluded that 1-alpha hydroxycholecalciferol appears to be effec-
tive therapy for renal osteodystrophy; that oral calcium therapy
may promote skeletal remineralization but that magnesium is
not an important factor in the etiology or treatment of renal
bone disease.
Assessment of renal osteodystrophy following renal trans-
plantation. A. M. Pierides, H A. Ellis, K. M. Peart, W. Simpson,
P. R. Uldall and D. N. S. Kerr. University of Newcastle-upon-
Tyne, EnglanL This study was undertaken to assess the effect
of transplantation on renal osteodystrophy. Twenty-four patients
had quantitative iliac crest bone biopsy histology at the time of
transplantation and then a year later. Nine patients were biopsied
at two years. Radiological skeletal surveys were taken at six
monthly intervals and biochemical estimations including para-
thyroid hormone (PTH) were performed throughout the follow-
up period. Twenty patients started with histological osteitis
fibrosa (OF) and 16 had osteomalacia (OM). At one year, 81%
of patients with OM and 45% of patients with OF completely
resolved. At two years four patients still showed mild OF (grades
1 -+ 1.5). Immunoreactive serum PTH levels remained high for
several months after transplantation but then spontaneously re-
turned to within normal limits for the assay used. Alkaline
phosphatase values in patients with OM remained high for
several months but gradually returned to normal in agreement
with histological findings. Radiological OF correlated well with
histological grades over 1.5 and Looser's zones appeared in
approximately 40% of patients with histological OM. Successful
renal transplantation results in rapid healing of OM and a slower
resolution of OF with excellent clinical improvement. OF
changes may be seen on bone histology two years after trans-
plantation in the presence of normal serum PTH concentrations.
Quantitative bone histology appears the most sensitive method
for assessing renal osteodystrophy.
Cyclophosphamide in the treatment of glomerulonephxitis.
J. T. BalslØv, C Brun, K. B. Jensen, F. JØrgensen, H. E. JØrgen-
sen, M. Larsen, 1. Lorenzen and Aa. C. Thomsen, Copenhagen,
Denmark. Fifty-six patients were included in a double-blinded
cross-over study of the effect of cyclophosphamide in glomeru-
lonephritis. On basis of the microscopic diagnosis of a kidney
biopsy specimen, the patients were allocated in pairs. One of
the pair was initially treated with cyclophosphamide, the other
with placebo. After a period of four months, cyclophosphamide
was exchanged with placebo and vice versa. Seventeen patients
did not fulfill the requirements for statistical analysis. Sixteen
patients were initially treated with placebo. Six patients im-
proved when changed to cyclophosphamide (decrease in pro-
teinuria of 50% and/or decrease in se-creatinine conc. of
> 25%), one patient deteriorated and nine patients were un-
changed. Twenty-three patients were initially treated with cyclo-
phosphamide. Ten deteriorated when changed to placebo (in-
crease in proteinuria of ' 50% and/or increase in se-creatinine
conc. of 25%), one patient improved and 11 patients were
unchanged. Conclusion. Cyclophosphamide has a statistically
significant effect (P > 0.01) in the treatment of glomerulone-
phritis. The remaining analytical results will be available at the
presentation.
A controlled trial of cyclophosphamide in proliferative
glomerulonephritis. A. M. Koelz, A. R. Morley, P. R. Uldall and
D. N. S. Kerr. University of Newcastle-upon-Tyne, England.
Forty-eight adult patients with proliferative glomerulonephritis
entered the trial. The patients were subdivided according to
three histological categories, namely early proliferative, late
proliferative (showing some nephron destruction) and prolifera-
tive with crescents; and according to initial renal function. With-
in these groupings they were randomly allocated to treatment
(24 patients) and control (24 patients). Treated patients re-
ceived cyclophosphamide, 1 to 2 mg/kg/day orally throughout
the trial period of at least one year. Clinical criteria, biochemical
indexes and repeat biopsy did not demonstrate a significant
difference between the groups. Eleven patients (five treated, six
controls) progressed to terminal renal failure. Eight (four in each
group) died. Side-effects of cyclophosphamide included leu-
copenia, alopecia, amenorrhoea, G.I. intolerance and one case of
fatal septicemia,
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Reversible acute anuric lupus nephritis. C. Ponticelli, E. Im-
basciat4 D. Brancaccio, A. Torantino and E. Rivolta. Sezione di
Nefrologia, Ospedale Polidilnico, Milano, Italy. Acute renal
failure, a rare complication of systemic lupus erythematosus, is
usually unresponsive to steroids and cytotoxic agents. Six cases
of acute anuric lupus nephritis are described; renal biopsy showed
intracapillary proliferation, epitheial crescents in some glom-
eruli, wire loops, intracapillary thrombi. In two patients there
are also thrombotic occlusions and fibrinoid necrosis of arte-
rioles. The patients were treated by heparin at anticoagulant
doses, steroids and dialysis (4). All patients showed improvement
of renal function. One died following a gastric hemorrhage. The
others are alive and well 59, 57, 36, 35 and 14 months from the
onset of renal failure. One patient had a second episode of
acute renal failure after 39 months and improved after re-
sumption of heparin therapy and high doses of steroids. It is
suggested that heparin and high doses of corticosteroids may be
a successful treatment in acute anuric lupus nephritis.
Immunofluorescence (IF) in 52 cases of lupus glomerulone-
phritis (GN). J Ph.. Mby, L. Morel-Maroger and J. Boelaert.
Hôpital Tenon, Paris, France. The purpose of this study was to
assess the diagnostic value of IF in lupus GN. Fluoresceinated
monospecific sera against human IgG, IgA, 1gM, j3lC and fib-
rinogen (fib) were used in 28 diffuse and 24 focal lupus GN.
Anti-Clq and anti-C4 were used in 11 proliferative (prolif)
diffuse and 11 focal GN, antiproperdin (p) and anti-C3PA in 6
diffuse and in 6 focal. In diffuse GN, nodular diffuse endo-
membranous deposits of IgG, plC, Clq, C4 and p were found,
respectively, in 27/28, 25/28, 8/11, 7/11 and 4/6 cases; focal
parietal 1gM and IgA were found respectively in 11 and 7 cases,
small foci of fib in 3; C3PA was only detected in 1/6. In focal
GN, diffuse predominantly mesangial deposits of IgG, plC, Clq
and p were found, respectively, in 23/24, 18/24, 7/11 and 3/6;
focal mesangial 1gM, IgA and fib were, respectively, found in
10, 8 and 4 cases; C4 was exceptional and C3PA, never present.
These patterns distinguish diffuse lupus GN from other diffuse
GN either primitive (membranoprolif, extracapillary, purely
endocapillary prolif.) or secondary (polyarteritis nodosa, Good-
pasture's syndrome, shunt GN), and focal GN both from Berger's
disease and from secondary focal GN (anaphylactoid purpura,
subacute endocarditis, polyarteritis nodosa). In association with
glomerular deposits, IgG aTnd/or IgA in arteriolar walls, granular
deposits of IgG, plC and Clq along tubular basement membrane,
found in approximately 25% cases, are highly contributive to
the diagnosis of lupus nephritis.
Complement deposition in glomerular diseases. Giovanni
Barbiano di Belgiofoso, Antonio Tarantino, Alessandra Durante,
Luisella Guerra (Intr. by L Minetti). Depts. of Nephrology,
Ospedale Maggiore Ca' Granda and Policlinico, Milan, Italy. Two
different mechanisms of complement activation are possibly in-
volved in human glomerulonephritis (GN), the classical and the
alternate pathway. In this work, the possible preeminent path-
way involved in the single GN is investigated. Three hundred
fifty biopsy specimens from patients with glomerular nephropa-
thies, both primary and secondary to systemic diseases, have
been studied by immunofluorescence. Besides immunoglobulins,
fibrinogen and albumin, staining was made with serums anti-Clq,
C4, C3 (direct technique) and C3 activator (C3A) (indirect
technique). In minimal change nephropathy and in mesangial
proliferative GN, only C3 was found in 40% of cases. In focal
glomerulosclerosis, mesangiocapillary GN, lupus nephritis, mixed
IgG-IgM essential cryoglobulinemia GN, staining for C3 was
positive in 90 to 100%. Clq and C4 in 75 to 80% of cases. In
membranous GN and in exudative proliferative GN, C3 was
present in 90 to 100% of cases, Clq in 10 to 20%, C4 in 30 to
40%. In focal GN with mesangial IgA deposits and in anaphylac-
toid purpura GN, C3 was positive in 90% of cases, while Clq and
C4 were rarely present. In proliferative GN with epithelial
crescents, C3 was always detected, both Clq and C4 in 50% of
cases. In three cases of Goodpasture's syndrome, C3 was always
found, while Clq and C4 were present in one and two cases,
respectively. C3A was observed in more than 60% of cases in
acute GN and in 50% of cases in cryoglobulinemia GN, in the
last one with a localization only on hyaline thrombi. C3A was
nearly absent in the other nephropathies. These results showed
a good relationship between site of deposits, their immuno-
globulin composition and presence of different complement
components.
The significance of extracapillary proliferation. I. A. Whit-
worth, L Morel-Maroger, Mignon and G. Richet. Service de
Néphrologie, Hôpital Tenon, Paris, France. Renal biopsy and
clinical data from 60 patients with extracapillary proliferation
(crescent formation) in > 50% of glomeruli were correlated.
31/60 (Group I) had> 80% crescents and 29/60 (Group II) 50
to 80% crescents. Immunofluorescence studies (IF) were per-
formed in 44. Six had linear fixation of IgG with anti-GBM anti-
body in 1/4. Diffuse granular immunoglobulin and complement
were found in 17 and focal deposits in 6. Thirty-six had fib-
rinogen, including 14 without immunoglobulin. In 35 the neph-
ropathy appeared primitive. Nephropathy appeared related to
infection (15 cases) malignancy (4) and trichlorethylene ex-
posure (2). Four cases were associated with extrarenal signs.
Isolated proteinuria was found 0.5 to 20 yr before biopsy in 16
patients. At presentation all patients had hematuria and pro-
teinuria, 18 were nephrotic, 21 oligo-anuric, 26 hypertensive
and 47 had impaired function. Twenty are dead (renal failure
and its complications, infection and malignancy) and 16 are
alive on the dialysis-transplant program. Sixteen (3 5%) are alive
with functioning kidneys. Nine have normal and ten, impaired
function. Outcome was significantly related to % crescentic in-
volvement (P < 0.02). Only one-half of group I could be regarded
as rapidly progressive glomerulonephritis on clinical criteria.
Oligo-anuria (P < 0.05) and renal function (P < 0.01) at presen-
tation were significantly related to outcome. Preceding infection
was of borderline significance. Extracapillary glomerulonephritis
is not a single entity.
Cryoglobulinemia in human glomerulonephritis: Diagnosis,
pronosis and significance. /. Conte, M. Blanc, M. Mignon- Conte,
M Abbal and C. Orfila, Centre d'Hemodialyse Piriodique,
C. H. R; Purpan, Toulouse, France. This work was investigated
to study the frequency and composition of cryoglobulins in 110
cases of primitive glomerulonephritis and 20 cases of lupus
nephritis, and to compare the nature of cryoprecipitates with
the intraglomerular deposits. The presence and nature. of cryo-
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globulins were studied using methods previously described by
R. M. McIntosh. Correlations with renal histology, immuno-
histology, renal function and immune serologic studies were
performed. Ninety-four blood donors were used as controls. The
discovery of a cryoglobulin is a -frequent phenomenon in primi-
live glomerulonephritis (49/1.10) and in lupus nephritis (14/20).
In primitive glomerulonephritis, the cryoglobulins are associated
in more than 2/3 of the cases (40/6 3) with a glomerular cellular
proliferation and glomerular deposits of C3. On the other hand,
cryoglobulins are rare in nonproliferative glomerulonephritis
(9/47) and absent in minimal glomerular changes (0/14). These
cryoproteins have been analyzed in 39 patients. In most cases
(33/39), there is a mixed cryoglobulinemia where IgG-IgM com-
plexes (22/33) clearly prevail isolated or associated with C3
(6/33). There is a good correlation between the presence of a
cryoglobulin and cellular glomerular proliferation; the persistence
of a cryoglobulin is an indication of bad prognosis in mesangial
glomerulonephritis with crescents; in lupus .nephritis, there is a
good correlation between the evolution of anti-DNA antibodies,
the complement level and the presence of a cryoglobulin.
Drug-induced hypersensitivity nephritis. Luigi Minett4 Gio-
vanni Barbiano di Belgiojoso, Giovanni Civati Alessandra
Durante, Francesco Ratti and C4zrIo Rovatf Divisione di Nefro-
logia dell'Ospedale Maggiore Ca' Granda, Milano, Italy. Authors
studied 13 patients with hypersensitivity nephritis to drugs, 12
of whom presented acute renal failure. Upon clinical and labora-
tory data, the causing agent has been found to be ampidillin in
two cases (1,2), penicillin and metidillin in one case (11),
rifampicin in three cases (6, 7, 13), sulfa drugs in three cases (3,
9, 10), methylglucamine diatrizoate in one case (12), while in
three cases the agent remained unknown (4, 5, 8). Clinical
manifestations of allergy were fever, erythema multiforme,
hepatitis, morbihiform rash in five cases (1, 2, 6, 7, 13), serum
sickness-type manifestations in three cases (9, 10, 11) and
cutaneous and systemic signs of allergic vasculitis in one case (8).
Renal needle biopsy showed in seven cases (1, 2, 3,4, 5, 6, 7) a
pattern of acute interstitial nephritis (AIN) with perivascular
cellular infiltration; in three cases (8, 9, 10) acute microscopic
nephroangioitis (AMN); and in one case (11) a mixed renal
lesion (Pan), in which there was concomitance of AN, AMN
and focal necrotizing glomerulonephritis. Finally, in one case
(12), a pattern of diffuse acute proliferative glomerulonephritis
(AGN) was observed. In four cases (1, 2, 3, 6) of MN, light
microscopy showed also important signs of acute microscopic
angioitis. By immunofluorescence, isolated deposition of C3 in
arterioles and mesangium was seen in seven cases (1, 2, 3, 5,6,9,
10) and only in mesangium in two cases (4, 7); fibrinogen was
found in the glomerular and interstitium in the case of Pan (11);
in the case of AGN (12), C3 was present on subepithelial humps.
In all cases remission of clinical manifestations and complete
recovery of renal function were obtained spontaneously or
after steroid therapy.
PiopranoIoI treatment of resistant arterial hypertension in
patients on Intermittent dialysis. G. Maggiore, M. Blagini, C.
Zoccali, M. Misefari and S. Sisca. Divislone Nefrologica "G.
Monasterio' Ospedali Riuniti Regglo Calabria, Italy. Among
51 patients treated by regular thrice-weekly hemodialysis in our
Center, 7 had severe persistent hypertension. All of them had
diastolic pressure above 130 mm Hg, grade III to IV retinopathy
and severe hypertensive cardiomiopathy. Plasma renin activity
while recumbent ranged from 5.93 to 12.16 ng/ml/hr (mean,
8.75 ng/ml/hr). Attempts to control blood pressure by in-
creasing sodium depletion with intensive ultrafiltration and
severe dietary sodium restriction were completely unsuccessful.
The patients were then treated with propranolol (160 to 320 mg/
day) and clonidine (0.300 mg/day). Diastolic blood pressure
dropped to nonnal values (diastolic pressure 90 mm Hg) in all
patients. Plasma renin activity fell to normal values in three,
while it persisted at high levels in the remaining patients. Com-
pliance of arterial pressure with drug treatment was assessed
several times in each patient. Drug discontinuation resulted in
prompt rebound of arterial pressure to pretreatment values.
However, hypertension was always controlled again on re-
swnption of drug treatment. At the moment of the present
writing, the duration of treatment ranges from 4 to 11 months,
and its effect on blood pressure has remained unchanged. No
adverse drug effect has been noted up to now. All patients are
well and fully rehabilitated. These results show that adequate
pharmacologic long-term control of so-called renin-dependent
hypertension can be achieved with propranolol therapy. How-
ever, the effect on blood pressure seems not to be mediated by
the suppression of renin secretion.
